Beta Drugs Fundamentals
P/E Ratio
47.8
P/B Ratio
4.72
Div. Yield
0
Sector P/E
40.5
Sector P/B
3.4
Sec. Div. Yield
0.52
Beta Drugs Fundamentals is currently trading with a P/E Ratio of 47.8, compared to the sector average of 40.5. Its P/B Ratio stands at 4.72, while the sector’s is 3.4. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.52%.
Beta Drugs Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Beta Drugs reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in BETA
